Patients with advanced prostate cancer may have cancer cells that spread to the bone and cause pain. A new drug shows promise by rapidly reducing prostate cancer bone tumors.

Men with castration-resistant prostate cancer have another treatment option. The US Food and Drug Administration (FDA) has approved the expanded use of Zytiga (abiraterone acetate).

You may have heard that a glass of red wine a day is good for your heart. Research now shows that the beneficial compound found in red wine may also help fight prostate cancer.

For men with aggressive prostate cancer, few treatment options are available. A new drug, however, showed a positive effect in reducing the number of tumor cells and cancer markers in advanced prostate cancer.

Prostate cancer is the most common non-skin cancer in men. While some specialty organizations recommend that screening begin at age 40, there is little evidence showing real benefits to screening at this age.

The brain releases a hormone to help with sleep when it’s dark called melatonin. But what happens with night workers? Is there danger in not generating any melatonin?

After prostate cancer patients receive treatment, they still run the risk of the disease coming back. A newly approved imaging agent offers a way to detect recurrence earlier.

Prostate cancer surgery patients commonly experience erectile dysfunction. While many seek therapy to regain function, they may need more partner support to stay with the program.